🇺🇸 FDA
Patent

US 9447417

Multiple exon skipping compositions for DMD

granted A61PA61P21/00A61P21/04

Quick answer

US patent 9447417 (Multiple exon skipping compositions for DMD) held by Sarepta Therapeutics, Inc. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P21/00, A61P21/04